Heading into 2025, patent applicants should prepare for significant fee increases at the United States Patent and Trademark Office (USPTO). These fee increases can significantly impact patent applicant behavior, leading prudent applicants to evaluate and adjust their patent protection strategies.
Rothwell Figg
Rothwell Figg Blogs
Latest from Rothwell Figg
FTC Says: If You Want to Use Data In a New Way, You Need to Provide Actual Notice to End-Users Before You Do It
It is fairly standard language in privacy policies: “This privacy policy may be amended or updated from time to time, so please check back regularly for updates.” It sends the message that the company can change its data practices and…
Client Spotlight: BASE Air Management
BASE Air is a company at the leading edge of safety in the heavy vehicle industry. Founded in 2005 by Matthew Vaughan in Australia, the company focuses on Balance and Safety Enhancement (BASE) for heavy-duty vehicle stability. BASE Air’s technology…
Gene Therapy Approvals Gain Steam in 2023: FDA Approves First Gene Therapies for Sickle Cell Disease
In a long-awaited milestone in the gene therapy space, the Food and Drug Administration (FDA) approved two gene therapies to cure sickle cell disease (SCD). Soon thereafter these approvals, a key licensing agreement was announced between Vertex and Editas for…
New BPCIA Case Filed: Genentech and Biogen Want to Stop Dr. Reddy’s Rituximab Biosimilar from Entering the U.S. Market
On November 17, 2023, Genentech, Hoffman-La Roche, and Biogen (collectively “plaintiffs”) filed a complaint in the federal district court for the District of New Jersey against Dr. Reddy’s Laboratories and Fresenius Kabi (collectively “defendants”) (DNJ No. 23-cv-22485). The plaintiffs allege…
Gene Therapy Approvals Gain Steam in 2023: Milestones in Second Half Pave Way for Transformative 2024
Gene therapy is part of a new wave of medicine that approaches disease treatment by addressing the root causes rather than focusing on treating or reducing symptoms. Currently, gene therapies are being developed for treatment of inherited diseases, autoimmune diseases,…
White House AI Order Balances Innovation And Regulation
On Oct. 30, President Joe Biden issued an executive order on safe, secure and trustworthy artificial intelligence.[1]
The executive order provides a sprawling list of directives aimed at establishing standards for AI safety and security and protecting privacy.
While the…
IP Innovation Management Webinar
IP Innovation Management is the subject of a webinar sponsored by Medmarc Insurance Group. This event will be presented by James Hastings of Rothwell Figg. He is the editor of Healthcare Marketing Law.
IP Innovation Management is a process for:…
The PREVAIL Act – Does it Unfairly Hinder Patent Challengers’ Possibility of Prevailing at the PTAB?
The Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act was introduced on June 22, 2023, with the aim to reform the U.S. Patent Trial and Appeal Board (PTAB). The PREVAIL Act serves as a supplement to the proposed…
FTC Launches Investigation into OpenAI
Following its many warnings of impending enforcement action against entities providing Artificial Intelligence (“AI”) products, the FTC has officially launched an investigation into OpenAI[1]. The FTC initiates its investigation on the heels of the Center for AI and…